DeePathology Launches an advanced Do It Yourself AI Platform – the SUTDIO™ Would you like to see how it can help you ? Bring along your slides to ECP in NICE !
Ra’anana, Israel August 27, 2019 — DeePathology is launching the STUDIO™, the world’s most advanced do-it-yourself AI platform that aims to save the most expensive resource in pathology – the time of the expert pathologist and researcher! By leveraging deep learning technology to facilitate the screening and classification of biopsies, DeePathology is helping pathologists keep pace with the mounting number of biopsies to be tested every year with greater laboratory quality and precision while lowering costs.™
“DeePathology’s STUDIO™ aims to bring AI technology to the desktop of the pathologist,” says Dr. Chen Sagiv, DeePathology CEO and co-founder. “Tasks such as cell detection, tissue segmentation, tissue classification and object quantification are common in pharmaceutical research, for example in pre-clinical and clinical trials as well as in disease research. The pathologist has to count or asses the size of different kinds of objects, such as cells.”
These tasks are tedious, time consuming and are prone to inaccuracies and errors. Addressing and mitigating these common pitfalls, is exactly where DeePathology’s STUDIO™ can help. DeePathology’s STUDIO™ comes with generic modules for cell detection, tissue segmentation, tissue classification, and object detection. However, the STUDIO™ is exceptional in its ability to expertly customize these generic capabilities through the implementation of sophisticated data annotation technology, to meet the specific needs of the pathologist or researcher. We believe the development of advanced, proprietary AI technology for annotation is the key to optimizing the time of the pathologist or researcher. The STUDIO™ allows for an accessible and smooth user experience without compromising on a robust machine-learning system that cleverly selects examples for annotation to maximize the performance of the neural network.
“Our aim was to use state-of-the-art deep learning technology to create a platform that really serves pathologists,” says Jacob Gildenblat, DeePathology CTO and co-founder. “We have put a lot of effort into creating an easy-to-use, interactive annotation utility that feels like a computer game. Moreover, the system quickly learns the features of interest and an auto annotation mode accelerates the annotation process significantly. The system suggests annotations, however the sole decision maker is the human expert.”
The STUDIO™ is in use in various sites for advanced evaluation, mainly in Europe. It has been used for the creation of several solutions such as β-Amyloid plaques segmentation, classification and quantification in IHC for Alzheimer research, Mast Cell Granulation/Degranulation quantification, H. Pylori detection, quantification of lymphocyte cells and more
DeePathology will be demonstrating the STUDIO™ in the upcoming ECP conference in Nice. If you will be participating in this event, Nizan Sagiv, DeePathology chairman and co-founder, has an offer for you: ”We encourage pathologists and researchers to bring their digitized slides to the event to see how DeePathology’s STUDIO™ can be used in real time to find cells and objects of interest.”
Sounds interesting? Drop Nizan an email to schedule a personal session: nizan@deepathology.ai
Source: DeePathology LTD
